famotidine has been researched along with Anemias, Iron-Deficiency in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 59-year-old man was orally administered rabeprazole, a proton pump inhibitor (PPI), for gastroesophageal reflux disease, after which he gradually developed iron-deficiency anemia." | 3.80 | Iron-deficiency anemia caused by a proton pump inhibitor. ( Chonan, A; Hashimoto, R; Matsuda, T, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, R | 1 |
| Matsuda, T | 1 |
| Chonan, A | 1 |
1 other study available for famotidine and Anemias, Iron-Deficiency
| Article | Year |
|---|---|
Iron-deficiency anemia caused by a proton pump inhibitor.
Topics: Anemia, Iron-Deficiency; Famotidine; Gastroesophageal Reflux; Humans; Male; Middle Aged; Proton Pump | 2014 |